Implantable cardioverter defibrillator following acute myocardial infarction: the '48-hour' and '40-day' rule

Research output: Contribution to journalArticle

Standard

Implantable cardioverter defibrillator following acute myocardial infarction: the '48-hour' and '40-day' rule. / Lim, Hoong; Lip, Gregory; Tse, HF.

In: Europace, Vol. 10, No. 5, 07.04.2008, p. 536-9.

Research output: Contribution to journalArticle

Harvard

APA

Vancouver

Author

Bibtex

@article{aeba9699994d44229d701f913a277d0d,
title = "Implantable cardioverter defibrillator following acute myocardial infarction: the '48-hour' and '40-day' rule",
abstract = "Until recently, randomized studies of implantable cardioverter defibrillator (ICD) have only included patients with a remote history of myocardial infarction (MI). Two studies evaluated the use of ICDs early following MI, the DINAMIT and BEST+ICD studies, but failed to demonstrate significant reduction in mortality. Current guidelines therefore recommend deferring ICD implantation for at least 40 days following MI. This article highlights the limitations of these two studies and reviews the application of the '40-day' rule to patients with acute MI.",
author = "Hoong Lim and Gregory Lip and HF Tse",
year = "2008",
month = apr,
day = "7",
doi = "10.1093/europace/eun070",
language = "English",
volume = "10",
pages = "536--9",
journal = "Europace",
issn = "1099-5129",
publisher = "Oxford University Press",
number = "5",

}

RIS

TY - JOUR

T1 - Implantable cardioverter defibrillator following acute myocardial infarction: the '48-hour' and '40-day' rule

AU - Lim, Hoong

AU - Lip, Gregory

AU - Tse, HF

PY - 2008/4/7

Y1 - 2008/4/7

N2 - Until recently, randomized studies of implantable cardioverter defibrillator (ICD) have only included patients with a remote history of myocardial infarction (MI). Two studies evaluated the use of ICDs early following MI, the DINAMIT and BEST+ICD studies, but failed to demonstrate significant reduction in mortality. Current guidelines therefore recommend deferring ICD implantation for at least 40 days following MI. This article highlights the limitations of these two studies and reviews the application of the '40-day' rule to patients with acute MI.

AB - Until recently, randomized studies of implantable cardioverter defibrillator (ICD) have only included patients with a remote history of myocardial infarction (MI). Two studies evaluated the use of ICDs early following MI, the DINAMIT and BEST+ICD studies, but failed to demonstrate significant reduction in mortality. Current guidelines therefore recommend deferring ICD implantation for at least 40 days following MI. This article highlights the limitations of these two studies and reviews the application of the '40-day' rule to patients with acute MI.

U2 - 10.1093/europace/eun070

DO - 10.1093/europace/eun070

M3 - Article

C2 - 18367548

VL - 10

SP - 536

EP - 539

JO - Europace

JF - Europace

SN - 1099-5129

IS - 5

ER -